Large-scale testing (Phase 3)Active Not RecruitingNCT04468659
What this trial is testing
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
Who this might be right for
Preclinical Alzheimer's DiseaseEarly Preclinical Alzheimer's Disease
Eisai Inc. 1,400